AIDS Treatment NewsImportant note: Information in this article was accurate in 2004. The state of the art may have changed since the publication date.
Click here to return to AIDS Treatment News main menu
Print this Article

DonateNow



Sculptra (formerly New Fill) for Facial Wasting -- Where to Find Information on the Patient-Assistance Program

AIDS TREATMENT NEWS - December 31, 2004
John S. James


Summary: Dermik Laboratories is now starting a patient-assistance program that provides free or low-cost drug to patients that meet certain imcome and other eligibility requirements. Information is changing rapidly, so we provide Web, email, and telephone sources to check.


Sculptra™ (marketed in some countries as New Fill™) was approved in August 2004 by the FDA "for restoration and/or correction of the signs of facial fat loss (lipoatrophy) in people with human immunodeficiency virus." It was approved narrowly for this use because of the great need of many patients -- but the FDA wants to see more data before allowing its wider use for cosmetic purposes, where the need is not as great.

The product is expensive in the U.S. (about three times the price in Europe) -- in addition to the cost of doctors' services, which can vary greatly. It is important to find a physician who is well trained or experienced in its use.

Dermik Laboratories (owned by Sanofi-Aventis), the company now selling Sculptra in the U.S., is setting up a patient-assistance program that will provide free or reduced-cost drug to patients who meet certain income and other eligibility requirements. It does not pay the doctors' bill, however. The key issue will be to get Sculptra covered by regular health insurance, like other reconstructive medicine. Some companies are refusing to pay for it by claiming it is "cosmetic." But many patients cannot maintain their job or career without the treatment.

Information about Sculptra -- choosing a doctor, getting coverage through one's health insurance, or getting patient assistance if insurance is not available -- is changing rapidly:

You could also use a Google search, such as "Sculptra patient assistance" (without the quotes), or "Sculptra 2005" (also without the quotes) to locate recent articles.

A background article by Bob Roehr in the Dallas Voice, published December 2004 or earlier, is at http://www.dallasvoice.com/articles/dispArticle.cfm?Article_ID=4418

041231
ATN041203


Copyright © 2004 - by John S. James. See "Permission to Copy" at: http://www.aidsnews.org/canhelp. How to help AIDS Treatment News: http://www.aidsnews.org/canhelp.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .